ARTICLE | Emerging Company Profile

BioCentury’s 2021 class of emerging companies

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

February 2, 2022 11:51 PM UTC

The class of innovators in BioCentury’s 2021 Emerging Company Profiles showcases evolving approaches to overcoming the challenges of new modalities.

The collection, which includes 118 start-ups, focuses on private biopharmas developing novel platforms or building first-in-class or best-in-class pipelines, that typically have emerged from stealth or raised their first venture rounds in the past three years. The series represents a curated group of companies with compelling science, rather than a comprehensive collection of newcos...